Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in providing high-quality chemical compounds essential for pharmaceutical development. Moclobemide (CAS 71320-77-9) is one such compound, recognized for its significant therapeutic applications as a selective monoamine oxidase type A (MAO-A) inhibitor. This article explores its chemical characteristics and how these properties translate into effective treatment strategies for mood disorders.
Moclobemide, with the molecular formula C13H17ClN2O2 and a molecular weight of 268.74 g/mol, is typically presented as a white to off-white solid. Its solubility in common organic solvents like DMSO and ethanol, alongside partial solubility in water, facilitates its formulation into various pharmaceutical dosage forms. The compound's structure, 4-chloro-N-[2-(4-morpholinyl)ethyl]benzamide, is key to its pharmacological activity. This chemical architecture allows it to act as a reversible inhibitor specifically targeting the MAO-A enzyme.
The therapeutic relevance of Moclobemide stems directly from its moclobemide mechanism of action. By selectively inhibiting MAO-A, it prevents the breakdown of vital monoamine neurotransmitters, including serotonin and norepinephrine. This leads to increased levels of these neurotransmitters in the brain, which is instrumental in alleviating symptoms of depression and anxiety. This selective action distinguishes it from older MAOIs that inhibit both MAO-A and MAO-B, often leading to more side effects and dietary restrictions. Therefore, Moclobemide is recognized as one of the safe MAOIs for depression.
The reversible nature of Moclobemide's inhibition is another critical aspect. Unlike irreversible inhibitors, Moclobemide's binding to MAO-A is temporary. This reversibility greatly reduces the risk of adverse interactions, particularly the tyramine pressor response that is a hallmark danger of older MAOIs. While it is still important to be aware of potential moclobemide drug interactions with certain concomitant medications, the overall safety profile is substantially enhanced. The combination of moclobemide vs older MAOIs clearly favors Moclobemide for its improved tolerability and reduced dietary restrictions.
The consistent moclobemide uses and side effects profile has made it a valuable therapeutic agent. Its efficacy in treating major depressive disorder and anxiety disorders, coupled with its favorable safety characteristics, underscores its importance in modern pharmacotherapy. NINGBO INNO PHARMCHEM CO.,LTD. is committed to producing Moclobemide to the highest purity standards, supporting the global pharmaceutical industry in delivering effective and safe treatments for mental health conditions.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
